EU drug regulator backs omicron-adapted COVID-19 booster shots

Published: Updated:
Read Mode
100% Font Size
1 min read

The EU’s drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the omicron variant and developed by rivals Moderna and Pfizer-BioNTech, as the region readies to roll out shots to ward off infections in the winter.

The new so-called bivalent shots combat the BA.1 version of omicron and the original virus first detected in China.

Read the latest updates in our dedicated coronavirus section.

The recommendations are for people aged 12 years and above who have received at least primary vaccination against COVID-19, the European Medicines Agency (EMA) said.

For the latest headlines, follow our Google News channel online or via the app.

The final go-ahead will be subject to European Commission approval, which should come in fairly quickly.

Read more:

Drugmakers hunt for one vaccine to target all COVID-19 variants

Top Content Trending